Menu

Webinar

Doctors Innovate Fund: Last Call

FFDR Ron and Ludwig

The deadline for the Doctors Innovate Fund is around the corner, and the team is ready to deploy capital and build the portfolio. Join Managing Partners Ron Levin and Ludwig Schulze to hear about the kinds of investments that the fund will make and how they build a fully diversified venture portfolio.

Watch on-demand below.

See video policy below.

Alumni Ventures’ Doctors Innovate Fund is a venture capital fund focusing on innovations founded by doctors and serial medical entrepreneurs tackling major healthcare problems.

During the session, we discussed:

  • Home

    The goal and structure of the fund
  • Home

    Benefits of diversifying into venture capital
  • Home

    Minimum requirements needed to invest in the fund
About Alumni Ventures

Top 20 VC Investors in North America (2024)

#1 Most Active Venture Firm in the U.S. (2023)

#1 Most Active Venture Firm in the U.S. (2022)

World's Most Innovative Companies (2022)

Note: You must be accredited to invest in venture capital. Important disclosure information can be found at av-funds.com/disclosures. 

About your presenters

Ludwig Pierre Schulze
Ludwig Pierre Schulze

Managing Partner, Doctors Innovate Fund

Ludwig has been on all sides of venture — as an entrepreneur, corporate buyer of ventures, and venture capitalist. Before Alumni Ventures, he experienced the daily realities of entrepreneurship as Founder and CEO of a mobile payments venture that served over 12 million people. Earlier, at a Fortune 100 telecommunications manufacturer (Nokia), he held general manager and business development roles that included investing in and acquiring venture-backed businesses. His first experience in venture capital was with an $800 million global fund that focused on enterprise and mobile software both before and after the dot.com crash. Ludwig began his career as a strategy consultant with the Boston Consulting Group. He has a BA from Brown University and an MBA from Columbia. He lives in NYC with his wife and 2 teenagers.

Ron Levin
Ron Levin

Managing Partner, Doctors Innovate Fund

Ron has spent his career in a variety of entrepreneurial, leadership, and business development roles. He has been an angel investor and advisor to over a dozen technology startups. Ron was Co-Founder and CEO of TravelPerk, a VC-backed travel management platform that is now a “unicorn” company with thousands of employees and customers across the globe. Prior to TravelPerk, he started the B2B division of Booking.com and before that was a consultant with McKinsey & Co. Ron began his career at Lycos, one of the web’s pioneer search engine and web portals. Ron graduated from Babson College and received his MBA from Harvard Business School. He is the author of the impact-focused Higher Purpose Venture Capital Blog.

Webinar Registration

Follow us

AV Headquarters
670 N. Commercial Street
Suite 403
Manchester, NH 03101
General inquiries: [email protected]

Press inquiries: [email protected]

603-518-8112

Follow us

Neither Alumni Ventures nor any of its funds are sponsored by, affiliated with, or otherwise endorsed by any university. For further details see our Legal & Privacy Policy.

Video Policy: By consuming this content I acknowledge that I may be considering an investment with AV funds for my own or my client’s account. I agree that information contained herein may not be relied upon or used for any other purpose. Offers to purchase securities are only made through formal offering documents, which describe risks (which are significant), terms, and other important information that must be considered before an investment decision is made. To see Important Disclosure Information, visit: https://av-funds.com/disclosures.

Testimonial/Endorsement Policy: Testimonials/Endorsements were provided by the participants without compensation, but each participant has a relationship with Alumni Ventures (AV) from which they benefit. All views expressed are the individual’s own and do not represent the experience of all AV fund investors or companies in which AV funds invest. Please note that testimonials are no guarantee of future performance or success. Any provider of an endorsement that is affiliated with a portfolio company Alumni Ventures has received investment funding from AV, and may in the future seek and/or receive additional funding from AV. This circumstance constitutes a conflict of interest. Providers of testimonials or endorsements were not chosen at random or according to any objective basis, but rather on the basis of their relationship with AV.

Investor Portal Update Policy: Investor portfolio data is updated once per quarter in the AV Investor Portal.

Alumni Ventures is America’s largest VC firm for individual investors based on the combination of total capital raised, number of investments, and number of investors of leading VC firms as reported by Pitchbook and other publicly available information reviewed by AV.

(1) Internal Rate of Return (IRR) for AV Funds is net of management fees and incentive allocations applied to amounts distributed to investors, and gross of incentive allocations applicable to unrealized gains on investments held by AV Funds. IRR for AV Funds includes uninvested cash, unrealized investments, and amounts distributed to investors. The IRR shown for the Russell 2000 indices are gross of fees because indices are not managed investments, and it is not possible to invest directly in an index. For additional information see av-funds.com/disclosures. All investment involves risk, including risk of loss. Past performance is not necessarily indicative of future results. For more information on AV Funds’ investment returns, please see here.

To see additional risk factors and investment considerations, visit: https://av-funds.com/disclosures

© 2024, Alumni Ventures. All rights reserved.